LAB Historical PE Ratio image   This LAB PE ratio history page last updated 2/1/2023
LAB Historical PE Ratio Chart
PeriodPriceAdj. EPSAnnualizedPE
Q3 2022
11/8/2022
0.98-0.26-1.04NA
Q2 2022
8/8/2022
2.04-0.33-1.32NA
Q1 2022
5/5/2022
3.01-0.25-1.00NA
Q4 2021
2/17/2022
3.36-0.01-0.04NA
Q3 2021
11/8/2021
4.82-0.07-0.28NA
Q2 2021
8/5/2021
6.83-0.12-0.48NA
Q1 2021
5/6/2021
4.59-0.15-0.60NA
Q4 2020
2/10/2021
7.09-0.13-0.52NA
Q3 2020
11/5/2020
6.800.030.1256.7
Q2 2020
8/6/2020
6.79-0.07-0.28NA
Q1 2020
5/7/2020
4.32-0.13-0.52NA
Q4 2019
2/10/2020
3.71-0.03-0.12NA
Q3 2019
11/5/2019
5.11-0.09-0.36NA
Q2 2019
8/1/2019
12.15-0.10-0.40NA
Q1 2019
5/2/2019
13.69-0.14-0.56NA
Q4 2018
2/7/2019
8.55-0.06-0.24NA
Q3 2018
11/1/2018
7.18-0.13-0.52NA
Q2 2018
8/2/2018
6.46-0.17-0.68NA
Q1 2018
5/3/2018
6.21-0.16-0.64NA
Q4 2017
2/8/2018
5.78-0.08-0.32NA
Q3 2017
11/2/2017
5.79-0.25-1.00NA
Q2 2017
8/3/2017
3.11-0.31-1.24NA
Q1 2017
5/4/2017
5.02-0.33-1.32NA
Q4 2016
2/8/2017
6.22-0.32-1.28NA
Q3 2016
11/3/2016
4.46-0.38-1.52NA
Q2 2016
8/4/2016
10.72-0.34-1.36NA
Q1 2016
5/5/2016
9.34-0.40-1.60NA
Q4 2015
2/4/2016
6.33-0.24-0.96NA
Q3 2015
10/29/2015
7.38-0.15-0.60NA
Q2 2015
8/6/2015
19.93-0.20-0.80NA
Q1 2015
5/7/2015
37.43-0.25-1.00NA
Q4 2014
2/5/2015
38.76-0.39-1.56NA
Q3 2014
10/30/2014
29.22-0.49-1.96NA
Q2 2014
7/31/2014
28.63-0.45-1.80NA
Q1 2014
5/5/2014
39.05-0.57-2.28NA
Q4 2013
2/6/2014
46.07-0.15-0.60NA
Q3 2013
10/30/2013
25.33-0.17-0.68NA
Q2 2013
8/1/2013
17.79-0.07-0.28NA
Q1 2013
5/1/2013
16.53-0.14-0.56NA
Q4 2012
2/12/2013
16.69-0.14-0.56NA
Q3 2012
11/7/2012
15.13-0.12-0.48NA
Q2 2012
8/7/2012
13.69-0.22-0.88NA
Q1 2012
5/2/2012
15.17-0.33-1.32NA
LAB PE History Chart
PeriodPriceAdj. EPSTTMPE
Q3 2022
11/8/2022
0.98-0.26-0.85NA
Q2 2022
8/8/2022
2.04-0.33-0.66NA
Q1 2022
5/5/2022
3.01-0.25-0.45NA
Q4 2021
2/17/2022
3.36-0.01-0.35NA
Q3 2021
11/8/2021
4.82-0.07-0.47NA
Q2 2021
8/5/2021
6.83-0.12-0.37NA
Q1 2021
5/6/2021
4.59-0.15-0.32NA
Q4 2020
2/10/2021
7.09-0.13-0.30NA
Q3 2020
11/5/2020
6.800.03-0.20NA
Q2 2020
8/6/2020
6.79-0.07-0.32NA
Q1 2020
5/7/2020
4.32-0.13-0.35NA
Q4 2019
2/10/2020
3.71-0.03-0.36NA
Q3 2019
11/5/2019
5.11-0.09-0.39NA
Q2 2019
8/1/2019
12.15-0.10-0.43NA
Q1 2019
5/2/2019
13.69-0.14-0.50NA
Q4 2018
2/7/2019
8.55-0.06-0.52NA
Q3 2018
11/1/2018
7.18-0.13-0.54NA
Q2 2018
8/2/2018
6.46-0.17-0.66NA
Q1 2018
5/3/2018
6.21-0.16-0.80NA
Q4 2017
2/8/2018
5.78-0.08-0.97NA
Q3 2017
11/2/2017
5.79-0.25-1.21NA
Q2 2017
8/3/2017
3.11-0.31-1.34NA
Q1 2017
5/4/2017
5.02-0.33-1.37NA
Q4 2016
2/8/2017
6.22-0.32-1.44NA
Q3 2016
11/3/2016
4.46-0.38-1.36NA
Q2 2016
8/4/2016
10.72-0.34-1.13NA
Q1 2016
5/5/2016
9.34-0.40-0.99NA
Q4 2015
2/4/2016
6.33-0.24-0.84NA
Q3 2015
10/29/2015
7.38-0.15-0.99NA
Q2 2015
8/6/2015
19.93-0.20-1.33NA
Q1 2015
5/7/2015
37.43-0.25-1.58NA
Q4 2014
2/5/2015
38.76-0.39-1.90NA
Q3 2014
10/30/2014
29.22-0.49-1.66NA
Q2 2014
7/31/2014
28.63-0.45-1.34NA
Q1 2014
5/5/2014
39.05-0.57-0.96NA
Q4 2013
2/6/2014
46.07-0.15-0.53NA
Q3 2013
10/30/2013
25.33-0.17-0.52NA
Q2 2013
8/1/2013
17.79-0.07-0.47NA
Q1 2013
5/1/2013
16.53-0.14-0.62NA
Q4 2012
2/12/2013
16.69-0.14-0.81NA
Q3 2012
11/7/2012
15.13-0.12NANA
Q2 2012
8/7/2012
13.69-0.22NANA
Q1 2012
5/2/2012
15.17-0.33NANA
Quotes delayed 20 minutes

Email EnvelopeFree LAB Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Standard BioTools (LAB) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

LABP PE Ratio History
LBPH PE Ratio History
LCI PE Ratio History
LFST PE Ratio History
LGND PE Ratio History
LGVN PE Ratio History
LH PE Ratio History
LHCG PE Ratio History
LHDX PE Ratio History
LIFE PE Ratio History
How should the LAB historical PE ratio be determined?
Realizing that PE stands for Price to Earnings ratio, we need two values to compute it: stock price and earnings per share. The stock price at any given date is a known historical value, but what about the earnings number to use?

✔️Accepted answer: There are a number of different approaches when it comes to calculating a historical PE ratio for a company like Standard BioTools. We like to take our measurements on each of the past quarterly earnings reports. That only leaves the question of whether the earnings number at that quarterly report should be used on an annualized basis, or some other method. We approach this question using three different methods, on this LAB Historical PE Ratio page.

What is the average historical PE for LAB based on annualized quarterly earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use that quarter's earnings result annualized?

✔️Accepted answer: The LAB historical PE ratio using the annualized quarterly earnings method works out to 56.7.

What is the average historical PE for LAB based on trailing twelve month earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the trailing twelve months combined earnings result in the calculation?

✔️Accepted answer: The LAB historical PE ratio using the TTM earnings method works out to NA.

On this page we presented the LAB Historical PE Ratio information for Standard BioTools' stock. The average LAB historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 56.7. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average LAB historical PE based on this TTM earnings result method is NA. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this LAB historical PE result, against the recent PE: when this page was posted on 1/31/2023, the most recent closing price for LAB had been 2.00, and the most recent quarterly earnings result, annualized, was 0.12. Meanwhile, the most recent TTM earnings summed to NA. From these numbers, we calculate the recent LAB PE on 1/31/2023 based on annualized quarterly EPS was 16.7. Based on LAB's history, that recent PE is low relative to the historical average, with the recent PE 70.5% lower than the historical average PE across our data set for Standard BioTools.

For self directed investors doing their due diligence on LAB or any other given stock, valuation analysis for LAB can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Standard BioTools PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for LAB. Thanks for visiting, and the next time you need to research LAB Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.

Recommended: GRUB Historical Stock Prices, RenaissanceRe Holdings Historical Earnings, Dividend ETFs.

 

LAB Historical PE Ratio | www.HistoricalPERatio.com | Copyright © 2020 - 2023, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.